Company · CIK 0000920148 · SIC 8071 — Services-Medical Laboratories · NYSE
LABCORP HOLDINGS INC. · LH
Insider activity reported against this company. All insider holders · Files at: SQNM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2016 FMForm 4 → | Feb 16, 4:25 pm EST | David P KingPresident & CEO, Director | 23,116 | $102.33 | $665,455 | 91,318 | — | plan? |
| Feb 11, 2016 FMForm 4 → | Feb 16, 4:24 pm EST | Edward T DodsonPrincipal Accounting Officer | 1,491 | $102.15 | $40,246 | 7,497 | — | plan? |
| Feb 11, 2016 FMForm 4 → | Feb 16, 4:23 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 4,280 | $102.18 | $109,023 | 6,748 | — | plan? |
| Feb 11, 2016 FMForm 4 → | Feb 16, 4:22 pm EST | Lance BerberianSVP, Chief Information Officer | 1,993 | $101.40 | $52,018 | 1,938 | — | plan? |
| Feb 11, 2016 FMForm 4 → | Feb 16, 4:21 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 1,585 | $102.11 | $41,354 | 18,436 | — | plan? |
| Jan 8, 2016 SForm 4 → | Jan 12, 4:51 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 1,215 | $119.05 | $144,646 | 18,066 | −6.30% | plan? |
| Dec 8, 2015 SForm 4 → | Dec 10, 4:38 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 1,010 | $123.31 | $124,543 | 19,281 | −4.98% | plan? |
| Nov 2, 2015 SForm 4 → | Nov 4, 3:20 pm EST | R Sanders WilliamsDirector | 1,850 | $124.30 | $229,949 | 4,176 | −30.7% | plan? |
| Nov 2, 2015 MForm 4 → | Nov 4, 3:20 pm EST | R Sanders WilliamsDirector | 1,850 | $64.42 | $119,177 | 6,026 | — | plan? |
| Oct 29, 2015 MForm 4 → | Nov 2, 2:31 pm EST | Kerrii B AndersonDirector | 1,296 | $59.37 | $76,944 | 13,035 | — | plan? |
| Aug 3, 2015 SForm 4 → | Aug 5, 3:53 pm EDT | David P KingPresident & CEO, Director | 50,000 | $127.93 | $6,396,342 | 81,153 | −38.1% | plan? |
| Aug 3, 2015 MForm 4 → | Aug 5, 3:53 pm EDT | David P KingPresident & CEO, Director | 50,000 | $80.37 | $4,018,500 | 131,153 | — | plan? |
| Jul 31, 2015 FMForm 4 → | Aug 4, 2:15 pm EDT | Joseph L HerringCEO of Covance Drug Division | 29,576 | $127.29 | $1,220,202 | 10,404 | — | plan? |
| Jul 1, 2015 SForm 4 → | Jul 6, 9:08 pm EDT | David P KingPresident & CEO, Director | 50,000 | $121.78 | $6,089,023 | 66,063 | −43.1% | plan? |
| Jul 1, 2015 MForm 4 → | Jul 6, 9:08 pm EDT | David P KingPresident & CEO, Director | 50,000 | $80.37 | $4,018,500 | 116,063 | — | plan? |
| Jun 16, 2015 FMForm 4 → | Jun 18, 4:07 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 5,646 | $120.48 | $192,286 | 4,602 | — | plan? |
| Jun 1, 2015 SForm 4 → | Jun 3, 4:17 pm EDT | David P KingPresident & CEO, Director | 50,000 | $118.58 | $5,928,846 | 65,899 | −43.1% | plan? |
| Jun 1, 2015 MForm 4 → | Jun 3, 4:17 pm EDT | David P KingPresident & CEO, Director | 50,000 | $80.37 | $4,018,500 | 115,899 | — | plan? |
| May 19, 2015 SForm 4 → | May 21, 1:30 pm EDT | Robert E Mittelstaedt Jr.Director | 1,296 | $119.02 | $154,254 | 10,111 | −11.4% | plan? |
| May 19, 2015 MForm 4 → | May 21, 1:30 pm EDT | Robert E Mittelstaedt Jr.Director | 1,296 | $59.37 | $76,944 | 11,407 | — | plan? |
| May 11, 2015 SForm 4 → | May 14, 10:58 am EDT | R Sanders WilliamsDirector | 965 | $118.05 | $113,914 | 4,176 | −18.8% | plan? late |
| Apr 29, 2015 SForm 4 → | May 1, 5:14 pm EDT | Jean-Luc BelingardDirector | 1,542 | $123.10 | $189,820 | 29,426 | −4.98% | plan? |
| Apr 29, 2015 MForm 4 → | May 1, 5:14 pm EDT | Jean-Luc BelingardDirector | 1,542 | $49.93 | $76,992 | 30,968 | — | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 5:28 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 1,394 | $126.56 | $176,425 | 23,454 | −5.61% | plan? |
| Apr 1, 2015 MForm 4 → | Apr 3, 10:30 am EDT | Dwight Gary GillilandDirector | 172 | — | — | 1,675 | — | plan? |
| Mar 30, 2015 SForm 4 → | Apr 1, 8:35 pm EDT | Mark E BrecherCMO, LabCorp Diagnostics | 20,625 | $126.98 | $2,619,000 | 5,511 | −78.9% | plan? |
| Mar 30, 2015 AFMForm 4 → | Apr 1, 8:35 pm EDT | Mark E BrecherCMO, LabCorp Diagnostics | 19,891 | $88.76 | $1,719,412 | 26,136 | — | plan? |
| Mar 30, 2015 AFForm 4 → | Apr 1, 7:50 pm EDT | David P KingPresident & CEO, Director | 12,304 | $127.28 | $505,811 | 65,899 | — | plan? |
| Mar 30, 2015 AFForm 4 → | Apr 1, 7:48 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 3,938 | $127.28 | $161,900 | 24,848 | — | plan? |
| Mar 30, 2015 AFForm 4 → | Apr 1, 7:46 pm EDT | Edward T DodsonPrincipal Accounting Officer | 691 | $127.28 | $21,892 | 6,575 | — | plan? |
| Mar 30, 2015 AFForm 4 → | Apr 1, 7:44 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 691 | $127.28 | $21,892 | 20,291 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 4, 10:38 am EST | James T. Boyle Jr.EVP, Chief Operating Officer | 1,237 | $123.70 | $153,015 | 23,454 | −5.01% | plan? |
| Mar 2, 2015 FForm 4 → | Mar 4, 10:38 am EST | James T. Boyle Jr.EVP, Chief Operating Officer | 1,130 | $123.36 | $139,397 | 24,691 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 4, 10:37 am EST | Edward T DodsonPrincipal Accounting Officer | 154 | $123.36 | $18,997 | 6,228 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 4, 10:36 am EST | Mark E BrecherChief Medical Officer | 154 | $123.36 | $18,997 | 6,589 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 4, 10:35 am EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 155 | $123.36 | $19,121 | 19,944 | — | plan? |
| Mar 2, 2015 FForm 4 → | Mar 4, 10:33 am EST | David P KingPresident & CEO, Director | 3,515 | $123.36 | $433,610 | 61,543 | — | plan? |
| Feb 26, 2015 SForm 4 → | Mar 2, 4:26 pm EST | R Sanders WilliamsDirector | 2,267 | $123.96 | $281,025 | 5,141 | −30.6% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 27, 6:32 pm EST | Joseph L HerringCEO of Covance Drug Division | 36,876 | $121.64 | $4,485,430 | 0 | −100% | plan? |
| Feb 12, 2015 FMForm 4 → | Feb 17, 4:06 pm EST | Edward T DodsonPrincipal Accounting Officer | 725 | $116.84 | $20,798 | 6,382 | — | plan? |
| Feb 12, 2015 FMForm 4 → | Feb 17, 4:05 pm EST | David P KingPresident & CEO, Director | 12,215 | $116.84 | $460,934 | 65,058 | — | plan? |
| Feb 12, 2015 FMForm 4 → | Feb 17, 4:01 pm EST | Mark E BrecherChief Medical Officer | 724 | $116.84 | $20,681 | 6,743 | — | plan? |
| Feb 12, 2015 FMForm 4 → | Feb 17, 3:58 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 725 | $116.84 | $20,798 | 20,099 | — | plan? |
| Feb 12, 2015 FMForm 4 → | Feb 17, 3:57 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 2,050 | $116.84 | $59,588 | 2,148 | — | plan? |
| Feb 12, 2015 FMForm 4 → | Feb 17, 3:55 pm EST | James T. Boyle Jr.EVP, Chief Operating Officer | 8,457 | $116.84 | $267,213 | 29,704 | — | plan? |
| Feb 12, 2015 SForm 4 → | Feb 17, 3:55 pm EST | James T. Boyle Jr.EVP, Chief Operating Officer | 6,597 | $116.68 | $769,742 | 25,821 | −20.3% | plan? |
| Feb 11, 2015 FMForm 4 → | Feb 13, 5:44 pm EST | Edward T DodsonPrincipal Accounting Officer | 762 | $116.73 | $24,747 | 6,013 | — | plan? |
| Feb 11, 2015 FMForm 4 → | Feb 13, 5:10 pm EST | James T. Boyle Jr.EVP, Chief Operating Officer | 5,398 | $116.73 | $156,652 | 28,535 | — | plan? |
| Feb 11, 2015 FMForm 4 → | Feb 13, 4:54 pm EST | Mark E BrecherChief Medical Officer | 776 | $116.73 | $24,863 | 6,373 | — | plan? |
| Feb 11, 2015 FMForm 4 → | Feb 13, 4:44 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 861 | $116.73 | $26,614 | 19,730 | — | plan? |
| Feb 11, 2015 FMForm 4 → | Feb 13, 4:40 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 2,228 | $116.73 | $64,785 | 1,118 | — | plan? |
| Feb 11, 2015 FMForm 4 → | Feb 13, 4:39 pm EST | David P KingPresident & CEO, Director | 11,605 | $116.73 | $380,773 | 60,733 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 5:54 pm EST | Dwight Gary GillilandDirector | 1,503 | — | — | 1,503 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:16 pm EST | Peter M NeupertDirector | 1,503 | — | — | 3,671 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:11 pm EST | Garheng KongDirector | 1,503 | — | — | 2,127 | — | plan? |
| Feb 10, 2015 FMForm 4 → | Feb 12, 4:07 pm EST | Jean-Luc BelingardDirector | 1,654 | $115.39 | $17,424 | 29,426 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:06 pm EST | Kerrii B AndersonDirector | 1,503 | — | — | 11,739 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:04 pm EST | Robert E Mittelstaedt Jr.Director | 1,503 | — | — | 10,111 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:03 pm EST | Adam H SchechterDirector | 1,503 | — | — | 3,237 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:02 pm EST | R Sanders WilliamsDirector | 1,503 | — | — | 7,408 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2015 MForm 4 → | Jun 18, 4:07 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 4,050 | — | — | 17,867 | — | |
| Jun 1, 2015 MForm 4 → | Jun 3, 4:17 pm EDT | David P KingPresident & CEO, Director | 50,000 | — | — | 100,000 | — | |
| May 19, 2015 MForm 4 → | May 21, 1:30 pm EDT | Robert E Mittelstaedt Jr.Director | 1,296 | — | — | 0 | — | |
| Apr 29, 2015 MForm 4 → | May 1, 5:14 pm EDT | Jean-Luc BelingardDirector | 1,542 | — | — | 0 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 10:30 am EDT | Dwight Gary GillilandDirector | 172 | — | — | 1,237 | — | |
| Mar 30, 2015 MForm 4 → | Apr 1, 8:35 pm EDT | Mark E BrecherCMO, LabCorp Diagnostics | 19,200 | — | — | 3,800 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 8:06 pm EDT | Lance BerberianSVP, Chief Information Officer | 1,200 | — | — | 4,160 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:41 pm EDT | Mark E BrecherCMO, LabCorp Diagnostics | 1,230 | — | — | 2,904 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:39 pm EDT | James T. Boyle Jr.EVP,CEO of LabCorp Diagnostics | 8,870 | — | — | 23,155 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:36 pm EDT | Dwight Gary GillilandDirector | 1,237 | — | — | 1,409 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:28 pm EDT | Kerrii B AndersonDirector | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:27 pm EDT | Jean-Luc BelingardDirector | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:23 pm EDT | Garheng KongDirector | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:23 pm EDT | Robert E Mittelstaedt Jr.Director | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:21 pm EDT | Peter M NeupertDirector | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:14 pm EDT | Adam H SchechterDirector | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:13 pm EDT | R Sanders WilliamsDirector | 1,237 | — | — | 1,237 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:10 pm EDT | Edward T DodsonPrincipal Accounting Officer | 1,200 | — | — | 2,847 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:08 pm EDT | F Samuel Eberts IIIChief Legal Officer, Secretary | 1,390 | — | — | 3,204 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:07 pm EDT | Glenn A EisenbergChief Financial Officer, EVP | 4,880 | — | — | 21,917 | — | |
| Mar 11, 2015 AForm 4 → | Mar 13, 3:04 pm EDT | David P KingPresident & CEO, Director | 18,230 | — | — | 43,187 | — | |
| Feb 23, 2015 AForm 4 → | Feb 25, 9:01 pm EST | Joseph L HerringCEO of Covance Drug Division | 19,990 | — | — | 19,990 | — | |
| Feb 12, 2015 MForm 4 → | Feb 17, 4:06 pm EST | Edward T DodsonPrincipal Accounting Officer | 547 | — | — | 1,647 | — | |
| Feb 12, 2015 MForm 4 → | Feb 17, 4:05 pm EST | David P KingPresident & CEO, Director | 8,270 | — | — | 24,957 | — | |
| Feb 12, 2015 MForm 4 → | Feb 17, 4:01 pm EST | Mark E BrecherChief Medical Officer | 547 | — | — | 1,674 | — | |
| Feb 12, 2015 MForm 4 → | Feb 17, 3:58 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 547 | — | — | 1,814 | — | |
| Feb 12, 2015 MForm 4 → | Feb 17, 3:57 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 1,540 | — | — | 17,037 | — | |
| Feb 12, 2015 MForm 4 → | Feb 17, 3:55 pm EST | James T. Boyle Jr.EVP, Chief Operating Officer | 6,170 | — | — | 14,285 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 5:44 pm EST | Edward T DodsonPrincipal Accounting Officer | 550 | — | — | 2,194 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 5:10 pm EST | James T. Boyle Jr.EVP, Chief Operating Officer | 4,056 | — | — | 20,455 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 4:54 pm EST | Mark E BrecherChief Medical Officer | 563 | — | — | 2,221 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 4:44 pm EST | F Samuel Eberts IIIChief Legal Officer, Secretary | 633 | — | — | 2,361 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 4:40 pm EST | Glenn A EisenbergChief Financial Officer, EVP | 1,673 | — | — | 18,577 | — | |
| Feb 11, 2015 MForm 4 → | Feb 13, 4:39 pm EST | David P KingPresident & CEO, Director | 8,343 | — | — | 33,227 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 5:54 pm EST | Dwight Gary GillilandDirector | 1,503 | — | — | 172 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:16 pm EST | Peter M NeupertDirector | 1,503 | — | — | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:11 pm EST | Garheng KongDirector | 1,503 | — | — | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:07 pm EST | Jean-Luc BelingardDirector | 1,503 | — | — | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:06 pm EST | Kerrii B AndersonDirector | 1,503 | — | — | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:04 pm EST | Robert E Mittelstaedt Jr.Director | 1,503 | — | — | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:03 pm EST | Adam H SchechterDirector | 1,503 | — | — | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 4:02 pm EST | R Sanders WilliamsDirector | 1,503 | — | — | 0 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2016 PForm 4 → | Sep 7, 5:22 pm EDT | SEQUENOM INCSQNM | 36,649,440 | $2.40 | $87,958,656 | 119,551,297 | +44.2% | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.